Potassium Asparaginate/Magnesium Asparaginate Tender - 140510426

Procurement Summary

Country: Ukraine

Summary: Potassium Asparaginate/Magnesium Asparaginate Solution for Injections of 10 Ml; Validol Tablets 60 Mg Each; Dexamethasone, Solution for Injection 4Mg/Ml; Diphenhydramine, Solution for Injection, 10 Mg/Ml, 1 Ml Each; Acetylcyst...

Deadline: 05 May 2026

Posting Date: 01 May 2026

Other Information

Notice Type: Tender

TOT Ref.No.: 140510426

Document Ref. No.: UA-2026-04-30-005663-a

Competition: ICB

Financier: Self Financed

Purchaser Ownership: Public

Tender Value: UAH 253000

CPV Classification

33600000 - Pharmaceutical products
33620000 - Medicinal products for the blood, blood-forming organs and the cardiovascular system
33640000 - Medicinal products for the genitourinary system and hormones
33670000 - Medicinal products for the respiratory system

Purchaser's Detail

Name: Login to see tender_details

Address: Login to see tender_details

Email: Login to see tender_detailsLogin to see details

Tender Details

Potassium asparaginate/Magnesium asparaginate solution for injections of 10 ml; Validol tablets 60 mg each; Dexamethasone, solution for injection 4mg/ml; Diphenhydramine, solution for injection, 10 mg/ml, 1 ml each; Acetylcysteine ​​powder/granules 600 mg each; Dexketoprofen solution for injections of 25 mg/ml in 2 ml increments; Magnesium sulfate, solution for injection, 250 mg/ml, 10 ml each; Metoclopramide, solution for injection, 5 mg/ml, 2 ml each; Sodium thiosulfate solution for injection 300mg/ml 5ml; Ethyl alcohol 96% 100 ml.; Diosmin (combinations), tablets, 1000 each mg; Ethyl alcohol 70% 100 ml.; Ondansetron solution for injection 2 mg/ml in 4 ml; Inosine, solution for injection, 20 mg/ml, 10 ml each; Ceftriaxone/Sulbactam powder for solution for injection 1000 mg/500 mg; Piracetam, solution for injection, 200 mg/ml, 5 ml each; Furosemide, solution for injection, 10 mg/ml, 2 ml each; Ceftazidime, powder for injection 2.0 g; Citicoline solution for injection 250 mg/ml, ampoule of 2 ml; Chlorhexidine, solution for external use 0.05% per 100 ml; Cefepime, powder for injection 1.0; Rocuronium bromide, solution for injection, 10 mg/ml, 5 ml each; Hydrogen peroxide, solution, 3%, 100 ml each; Thiotriazoline, solution for injection, 25 mg/ml, 4 ml each Purchase type: goods Classifier and its corresponding code: DK 021:2015: 33600000-6 — Pharmaceutical products Ondansetron solution for injections of 2 mg/ml in 4 ml; Citicoline: Classification according to ATX: N06BX06, Classification according to INN: Citicoline, Release form: Solution for injections, Dose of active substance: 250 mg/ml, Volume: 2 milliliters, Packaging type: Ampoule; Classification according to ATX: D08AC02, INN: Chlorhexidine, Release form: Solution for external use, Dose of active substance: 0.05%, Volume: 100 ml, Type of packaging: Vial; Rocuronium bromide, solution for injection, 10 mg/ml, 5 ml each M03AC09, Rocuronium bromide, Solution for injection, 10 mg/ml, 5 ml, Ampoule, Vial Name Class...

Documents

 Tender Notice